Uptake of interferon‐free DAA therapy among HCV‐infected decompensated cirrhosis patients and evidence for decreased mortality
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13543
Abstract: Interferon‐free DAA therapies have recently been licensed for patients infected with hepatitis C virus (HCV) who have decompensated cirrhosis (DC). Our aim was to describe factors associated with uptake of IFN‐free DAAs in DC patients… read more here.
Keywords: interferon free; daa; daa era; mortality ... See more keywords
The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Viral Hepatitis"
DOI: 10.1111/jvh.13665
Abstract: The recently reported epidemic of acute hepatitis C virus (HCV) infections —observed predominantly among men who have sex with men (MSM)—may now decline due to wide availability of direct‐acting antivirals (DAAs). This study aimed to… read more here.
Keywords: acute hepatitis; daa era; era;
Barriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience
Sign Up to like & getrecommendations! Published in 2017 at "BMJ Open Gastroenterology"
DOI: 10.1136/bmjgast-2017-000181
Abstract: Background Cure rates for chronic hepatitis C have improved dramatically with direct-acting antivirals (DAAs), but treatment barriers remain. We aimed to compare treatment initiation rates and barriers across both interferon-based and DAA-based eras. Methods We… read more here.
Keywords: era; treatment; daa era; chronic hepatitis ... See more keywords